US FTC says it has shown Edwards-JenaValve deal likely creates monopoly
MLex Summary: The proposed transaction between Edwards Lifesciences and JenaValve is likely to lessen competition and tends to create a monopoly, the US Federal Trade Commission says it has proven. The...To view the full article, register now.
Already a subscriber? Click here to view full article